Reflectance Medical Inc. develops technology to revolutionize the care of critically ill patients by reducing medical costs and deaths associated with conditions which result in poor tissue perfusion and acidosis. The company's noninvasive CareGuide patient monitor continuously and quantitatively displays levels of microvascular oxygen, pH and hematocrit to provide treatment goals to assure rapid and successful reversal of microvascular abnormalities associated with internal bleeding, trauma, cardiac failure and sepsis
